The UK government has approved emergency use of the COVID-19 vaccine being developed by local pharmaceutical companies AstraZeneca and Oxford University.
The UK’s Ministry of Health said on the 30th that it had accepted the recommendations of the Drug Regulatory Authority (MHRA) and made the decision.
The UK is the first to approve emergency use of the AstraZeneca vaccine.
The UK is the first in the world to approve the emergency use of the Pfizer vaccine, and this time it has approved a second vaccine.
AstraZeneca vaccine will be available as early as the 4th of next month, local media said.
Health Minister Matt Hancock said today, “We will distribute the AstraZeneca vaccine as soon as possible,” he said. “This vaccine will be very helpful as the period between the first and second doses is up to 12 weeks.”
“Today is an important day for millions of British people who have received the new vaccine,” said AstraZeneca Pascal Sorio, CEO. “Our vaccine has been shown to be effective in preventing COVID-19. It is easy to store, simple to inoculate, and supplied without profit. “He emphasized.
However, it turns out that AstraZeneca did not apply to the European Union to approve’conditional sale’, or emergency use.
Noel Wasshun, deputy director of the European Medicines Agency (EMA), said in an interview with a Belgian daily newspaper on the 29th.
[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]